Dr. Dan Capampangan, MD
Claim this profileChandler Regional Medical Center
Studies Bleeding
Studies Stroke
1 reported clinical trial
2 drugs studied
Affiliated Hospitals
Clinical Trials Dan Capampangan, MD is currently running
More about Dan Capampangan, MD
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Dan Capampangan, MD has experience with
- Apixaban
- Aspirin
Breakdown of trials Dan Capampangan, MD has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dan Capampangan, MD specialize in?
Dan Capampangan, MD focuses on Bleeding and Stroke. In particular, much of their work with Bleeding has involved treating patients, or patients who are undergoing treatment.
Is Dan Capampangan, MD currently recruiting for clinical trials?
Yes, Dan Capampangan, MD is currently recruiting for 1 clinical trial in Chandler Arizona. If you're interested in participating, you should apply.
Are there any treatments that Dan Capampangan, MD has studied deeply?
Yes, Dan Capampangan, MD has studied treatments such as Apixaban, Aspirin.
What is the best way to schedule an appointment with Dan Capampangan, MD?
Apply for one of the trials that Dan Capampangan, MD is conducting.
What is the office address of Dan Capampangan, MD?
The office of Dan Capampangan, MD is located at: Chandler Regional Medical Center, Chandler, Arizona 85224 United States. This is the address for their practice at the Chandler Regional Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.